BRAF Mutation Testing and Metastatic Colorectal Cancer in the Community Setting: Is There an Urgent Need for More Education?

about

BRAF Mutation Testing and Metastatic Colorectal Cancer in the Community Setting: Is There an Urgent Need for More Education?

Item

http://www.wikidata.org/entity/Q50897558

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

BRAF Mutation Testing and Meta ...... rgent Need for More Education?

@en

BRAF Mutation Testing and Meta ...... rgent Need for More Education?

@nl

type

Item

label

BRAF Mutation Testing and Meta ...... rgent Need for More Education?

@en

BRAF Mutation Testing and Meta ...... rgent Need for More Education?

@nl

prefLabel

BRAF Mutation Testing and Meta ...... rgent Need for More Education?

@en

BRAF Mutation Testing and Meta ...... rgent Need for More Education?

@nl

P1476

BRAF Mutation Testing and Meta ...... rgent Need for More Education?

@en

P2093

Amanda Rose Townsend

http://www.w3.org/2001/XMLSchema#string

Carol Beeke

http://www.w3.org/2001/XMLSchema#string

Guy Maddern

http://www.w3.org/2001/XMLSchema#string

James Moore

http://www.w3.org/2001/XMLSchema#string

Louisa Lo

http://www.w3.org/2001/XMLSchema#string

Robert Padbury

http://www.w3.org/2001/XMLSchema#string

Roy Amitesh

http://www.w3.org/2001/XMLSchema#string

Timothy J Price

http://www.w3.org/2001/XMLSchema#string

P2860

BRAF mutations are associated with distinctive clinical, pathological and molecular features of colorectal cancer independently of microsatellite instability status.

Meta-analysis of BRAF mutation as a predictive biomarker of benefit from anti-EGFR monoclonal antibody therapy for RAS wild-type metastatic colorectal cancer

Predictive role of BRAF mutations in patients with advanced colorectal cancer receiving cetuximab and panitumumab: a meta-analysis.

Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations.

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

Smoking, gender, and ethnicity predict somatic BRAF mutations in colorectal cancer.

Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer

Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Progression-free survival remains poor over sequential lines of systemic therapy in patients with BRAF-mutated colorectal cancer

BRAF codons 594 and 596 mutations identify a new molecular subtype of metastatic colorectal cancer at favorable prognosis.

P2888

s40291-015-0179-7

P304

75-82

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40291-015-0179-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

David Roder

Christos S Karapetis

P577

2015-12-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26714964

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer